Search Results - "Benayed, R."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Identifying patients with NTRK fusion cancer by Solomon, J P, Benayed, R, Hechtman, J F, Ladanyi, M

    Published in Annals of oncology (01-11-2019)
    “…Due to the efficacy of tropomyosin receptor kinase (TRK) inhibitor therapy and the recent Food and Drug Administration approval of larotrectinib, it is now…”
    Get full text
    Journal Article
  2. 2

    Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients by Ross, D.S., Liu, B., Schram, A.M., Razavi, P., Lagana, S.M., Zhang, Y., Scaltriti, M., Bromberg, J.F., Ladanyi, M., Hyman, D.M., Drilon, A., Zehir, A., Benayed, R., Chandarlapaty, S., Hechtman, J.F.

    Published in Annals of oncology (01-08-2020)
    “…Kinase fusions are rare and poorly characterized in breast cancer (BC). We aimed to characterize kinase fusions within a large cohort of advanced BC. A total…”
    Get full text
    Journal Article
  3. 3

    Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder by GHARANI, N, BENAYED, R, MANCUSO, V, BRZUSTOWICZ, L. M, MILLONIG, J. H

    Published in Molecular psychiatry (01-05-2004)
    “…Mouse mutants of the homeobox transcription factor Engrailed2 (En2) and autistic individuals display similar cerebellar morphological abnormalities, which…”
    Get full text
    Journal Article
  4. 4

    Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis by Wang, J, Bansal, A T, Martin, M, Germer, S, Benayed, R, Essioux, L, Lee, J S, Begovich, A, Hemmings, A, Kenwright, A, Taylor, K E, Upmanyu, R, Cutler, P, Harari, O, Marchini, J, Criswell, L A, Platt, Adam

    Published in The pharmacogenomics journal (01-06-2013)
    “…Rheumatoid arthritis (RA) is an immune-mediated inflammatory disease affecting the joints. A heterogeneous response to available therapies demonstrates the…”
    Get full text
    Journal Article
  5. 5

    Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir by de Niet, A., Takkenberg, R.B., Benayed, R., Riley-Gillis, B., Weegink, C.J., Zaaijer, H.L., Koot, M., Jansen, P.L.M., Beld, M.G.H.M., Lopatin, U., Reesink, H.W.

    Published in Scandinavian journal of gastroenterology (01-04-2012)
    “…Abstract In a cohort of 95 chronic hepatitis B patients, who were treated with peg-interferon and adefovir for 1 year, and who had 15% HBsAg loss (overall), no…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Identifying patients with NTRK fusion cancer by Solomon, J P, Benayed, R, Hechtman, J F, Ladanyi, M

    Published in Annals of oncology (01-11-2019)
    “…Due to the efficacy of tropomyosin receptor kinase (TRK) inhibitor therapy and the recent Food and Drug Administration approval of larotrectinib, it is now…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Erratum: Association of the homeobox transcription factor, ENGRAILED 2, with autism spectrum disorder by Gharani, N, Benayed, R, Mancuso, V, Brzustowicz, L M, Millonig, J H

    Published in Molecular psychiatry (01-05-2004)
    “…Correction to: Mol Psychiatry (2004) 9, 474–484. doi:10.1038/sj.mp.4001498 Following publication of the above paper, the author has identified errors in the…”
    Get full text
    Journal Article
  12. 12